What does MED ASTRAGALE do?

MED ASTRAGALE is a general practice in Chastre. Private Limited, started on 29 April 2014, 1 establishment.

What is the address of MED ASTRAGALE?

The registered office of MED ASTRAGALE is located at Rue Ledocte 3, 1450 Chastre.

Is MED ASTRAGALE still active?

Yes. According to the CBE (31 October 2026) MED ASTRAGALE is active, legal situation “Normale toestand”, started on 29 April 2014.

Is MED ASTRAGALE registered on Peppol?

Yes, MED ASTRAGALE is registered on the Peppol network with ID 0208:0550977519.

What is the enterprise number of MED ASTRAGALE?

The enterprise number of MED ASTRAGALE is BE0550977519.

When was MED ASTRAGALE founded?

MED ASTRAGALE was founded on 29 April 2014.

Who are the directors of MED ASTRAGALE?

According to the 2025 annual accounts, the directors of MED ASTRAGALE are: Virginie Huyghe.

Is MED ASTRAGALE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 April 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MED ASTRAGALE make in 2025?

MED ASTRAGALE posted a profit after taxes of € 14,455 in financial year 2025.

What is the revenue of MED ASTRAGALE?

As a small company, MED ASTRAGALE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 26,803.

MED ASTRAGALE (Private Limited) - Chastre - BE0550977519

Dossier MED ASTRAGALE, printed on 31 October 2026 from databakkes.be/en/0550977519/med-astragale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MED ASTRAGALE from Chastre, company number BE0550977519, closed financial year 2025 with a result of € 14,455 after tax. For that financial year MED ASTRAGALE recorded a gross margin of € 26,803 and equity of € 18,600. Compared with financial year 2024, the result moved from € 21,103 to € 14,455. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 14,455

▼ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 19,744

▼ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 14,455 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,425

▼ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,142

▲ € 7,780 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,955

▼ 62% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 7,541 Gross margin 2022: € 7,541 First fiscal year in the series	€ 32,986 Gross margin 2023: € 32,986 ▲ € 25,445 vs 2022 (€ 7,541) Favourable step	€ 39,906 Gross margin 2024: € 39,906 ▲ 21% vs 2023 (€ 32,986) Favourable step	€ 26,803 Gross margin 2025: € 26,803 ▼ 33% vs 2024 (€ 39,906) Unfavourable step	▼ 33%
Profit after taxes	€ -793 Profit after taxes 2022: € -793 First fiscal year in the series	€ 19,963 Profit after taxes 2023: € 19,963 ▲ € 20,756 vs 2022 (€ -793) Favourable step	€ 21,103 Profit after taxes 2024: € 21,103 ▲ 6% vs 2023 (€ 19,963) Favourable step	€ 14,455 Profit after taxes 2025: € 14,455 ▼ 32% vs 2024 (€ 21,103) Unfavourable step	▼ 32%
Equity	€ 53,093 Equity 2022: € 53,093 First fiscal year in the series	€ 18,600 Equity 2023: € 18,600 ▼ 65% vs 2022 (€ 53,093) Unfavourable step	€ 18,600 Equity 2024: € 18,600 Unchanged (€ 18,600) Unchanged	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 13,508 Total debts 2022: € 13,508 First fiscal year in the series	€ 63,452 Total debts 2023: € 63,452 ▲ € 49,944 vs 2022 (€ 13,508) Unfavourable step	€ 37,246 Total debts 2024: € 37,246 ▼ 41% vs 2023 (€ 63,452) Favourable step	€ 28,419 Total debts 2025: € 28,419 ▼ 24% vs 2024 (€ 37,246) Favourable step	▼ 24%
Cash	€ 18,485 Cash 2022: € 18,485 First fiscal year in the series	€ 34,256 Cash 2023: € 34,256 ▲ 85% vs 2022 (€ 18,485) Favourable step	€ 34,840 Cash 2024: € 34,840 ▲ 2% vs 2023 (€ 34,256) Favourable step	€ 19,744 Cash 2025: € 19,744 ▼ 43% vs 2024 (€ 34,840) Unfavourable step	▼ 43%
Retained profit	€ 34,493 Retained profit 2022: € 34,493 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 34,493) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 54,456 Dividend 2023: € 54,456 Unchanged (€ 0) Unchanged	€ 21,103 Dividend 2024: € 21,103 ▼ 61% vs 2023 (€ 54,456) Unchanged	€ 14,455 Dividend 2025: € 14,455 ▼ 32% vs 2024 (€ 21,103) Unchanged	▼ 32%
Bank debt	€ 8,552 Bank debt 2022: € 8,552 First fiscal year in the series	€ 4,788 Bank debt 2023: € 4,788 ▼ 44% vs 2022 (€ 8,552) Favourable step	€ 965 Bank debt 2024: € 965 ▼ 80% vs 2023 (€ 4,788) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 965) Favourable step	▼ 100%
Balance sheet total	€ 66,601 Balance sheet total 2022: € 66,601 First fiscal year in the series	€ 82,052 Balance sheet total 2023: € 82,052 ▲ 23% vs 2022 (€ 66,601) Unchanged	€ 55,846 Balance sheet total 2024: € 55,846 ▼ 32% vs 2023 (€ 82,052) Unchanged	€ 47,019 Balance sheet total 2025: € 47,019 ▼ 16% vs 2024 (€ 55,846) Unchanged	▼ 16%

Key figures of MED ASTRAGALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MED ASTRAGALE?

What happened at MED ASTRAGALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 14,455 (▼ 32% vs 2024). Source: NBB ↗
Apr 29, 2014 New establishment in Chastre. KBO
2014 Virginie Huyghe became a director. NBB
Apr 29, 2014 Start of the company according to the CBE. KBO

In short

From € 793 loss in 2022 to € 14,455 profit in 2025.

Paid € 29,140 in corporate taxes since 2022.

Best year ever: 2024, with € 21,103 profit.

Paid out € 90,014 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Virginie Huyghe

MED ASTRAGALE

Behind MED ASTRAGALE is Virginie Huyghe.

Directors

According to the 2025 annual accounts

Virginie Huyghe

Director

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Ledocte 3

1450 Chastre

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0550.977.519
VAT number: BE 0550.977.519
Registered office: Rue Ledocte 3, 1450 Chastre
Names & denominations: MED ASTRAGALE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 April 2014
Peppol: Active · Active since 4 Sept 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗